OBO_ID (LABEL):	CHEBI_28934 (vitamin D2)

IGNORANCE CATEGORY:	problem_complication

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC4600246	10/2015	S69-PMC4600246	['the mechanisms responsible include (1) activation of growth-inhibiting proteins requiring Vitamin K2, such as prothrombin,62(2) Arylation pathways,63(3) activation of growth arrest Genes such as gas 6,64and (4) and increased C-Jun and C-Myc mrna Expression in Hepatoma Cells.57\npreventing the Recurrence of hcc is an IMPORTANT STRATEGY, ESPECIALLY CONSIDERING the fact that EVEN after patients undergo curative therapy recurrence rates REMAIN high.65while triple combination therapy with Boceprevir or Telaprevir, pegylated interferon (ifn) and Ribavirin is effective for the treatment of hepatitis c virus (Hcv), INFORMATION on preventing hcc development and/or recurrence as well as all-cause mortality is LACKING.6667moreover, this combination therapy is expensive, REQUIRES injections (ifn) and is OFTEN not well tolerated DUE TO adverse events (ie, fever and pancytopenia).']	[('IMPORTANT_CONSIDERATION', 317), ('FUTURE_WORK', 327), ('IMPORTANT_CONSIDERATION', 337), ('IMPORTANT_CONSIDERATION', 348), ('ANOMALY_CURIOUS_FINDING', 374), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 614), ('FULL_UNKNOWN', 708), ('INCOMPLETE_EVIDENCE', 708), ('IMPORTANT_CONSIDERATION', 769), ('PROBABLE_UNDERSTANDING', 802), ('PROBLEM_COMPLICATION', 827)]	12	[('CHEBI_28934', 'vitamin D2', 90, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 90, 'vitamin K2'), ('GO_0006915', 'apoptotic process', 128, 'arylation'), ('SO_0000704', 'gene', 181, 'genes'), ('PR_000004968', 'calretinin', 225, 'c-Jun'), ('PR_000000084', 'c-myc protein', 235, 'c-Myc'), ('GO_0010467', 'gene expression', 246, 'expression'), ('CL_0000632', 'hepatic stellate cell', 260, 'hepatoma cells'), ('GO_0000003', 'reproduction', 293, 'recurrence'), ('CHEBI_68621', 'boceprevir', 488, 'boceprevir'), ('CHEBI_68593', 'eurysterol B(1-)', 502, 'telaprevir'), ('CHEBI_63580', 'ribavirin', 545, 'ribavirin'), ('NCBITaxon_10088', 'Mus <genus>', 608, 'HCV')]
PMC5273824	1/2017	S27-PMC5273824	['RECENTLY, lc-ms/ms became the GOLD STANDARD of measuring Vitamin D level DUE TO its ability to DIFFERENTIATE and ACCURATELY quantify the two subgroups of 25-Oh Vitamin D (25-Oh Vitamin D2 and 25-Oh Vitamin D3); (2) high specificity, which allows DIFFERENTIATION of the target Molecule from other Metabolic intermediates, as well as avoiding INTERFERENCE as SEEN in immunological methods; (3) high sensitivity, which allows detection at ng/ml level.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 113), ('INCOMPLETE_EVIDENCE', 246), ('PROBLEM_COMPLICATION', 341), ('INCOMPLETE_EVIDENCE', 357)]	8	[('CHEBI_28384', 'vitamin K', 57, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 57, 'Vitamin D'), ('CHEBI_86030', 'O-(hydroxyhexadecanoyl)carnitine', 156, '-OH'), ('CHEBI_28384', 'vitamin K', 160, 'Vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 171, '25-OH'), ('CHEBI_28934', 'vitamin D2', 177, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 177, 'Vitamin D2'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 192, '25-OH'), ('CHEBI_33237', 'vitamin D4', 198, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 198, 'Vitamin D3'), ('CHEBI_36357', 'polyatomic entity', 276, 'molecule'), ('GO_0008152', 'metabolic process', 296, 'metabolic')]
